FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018368761> ?p ?o ?g. }

• W2018368761 endingPage "593" @default.
• W2018368761 startingPage "588" @default.
• W2018368761 abstract "We have previously found that restoration of tumor suppressive microRNA-1 (miR-1), induced cell apoptosis in bladder cancer (BC) cell lines. However, the apoptosis mechanism induced by miR-1 was not fully elucidated. Alternative splicing of mRNA precursors provides cancer cells with opportunities to translate many oncogenic protein variants, which promote cell proliferation and survival under unpreferable condition for cancer development. Serine/arginine-rich (SR) protein family, which involved in alternative pre-mRNA splicing, plays a critical role for regulating apoptosis by splicing apoptosis-related genes. However, transcriptional regulation of SR proteins, themselves, has not been elucidated. In this study, we focused on splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) on the basis of our previous genome-wide gene expression analysis using miR-1-transfected BC cell lines because putative target sites of miR-1 are existed in 3′-untranslated region (UTR) of SRSF9 mRNA. The expression levels of mRNA of SRSF9 were extremely reduced in the miR-1 transfectants. A luciferase activity significantly decreased in the transfectants suggesting that actual binding occurred between miR-1 and 3′UTR of SRSF9 mRNA. Loss-of-function assays demonstrated that significant inhibitions of cell proliferation, migration, and invasion were observed in the si-SRSF9 transfectants. Apoptosis assays demonstrated that cell apoptosis fraction increased and that caspase-3/7 was activated in the si-SRSF9 transfectants. Our data indicated that tumor suppressive miR-1 induces apoptosis through direct inhibition of SRSF9 in BC. The identification of molecular mechanisms between miRNAs and SR proteins could provide novel apoptosis pathways and their epigenetic regulations and offer new strategies for BC treatment." @default.
• W2018368761 created "2016-06-24" @default.
• W2018368761 creator A5007919399 @default.
• W2018368761 creator A5019395170 @default.
• W2018368761 creator A5025601550 @default.
• W2018368761 creator A5030624081 @default.
• W2018368761 creator A5038105097 @default.
• W2018368761 creator A5039590534 @default.
• W2018368761 creator A5043599617 @default.
• W2018368761 creator A5044574879 @default.
• W2018368761 creator A5057512397 @default.
• W2018368761 creator A5063448763 @default.
• W2018368761 creator A5081925386 @default.
• W2018368761 creator A5090365310 @default.
• W2018368761 date "2012-01-01" @default.
• W2018368761 modified "2023-10-15" @default.
• W2018368761 title "Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer" @default.
• W2018368761 cites W1966749076 @default.
• W2018368761 cites W1970108031 @default.
• W2018368761 cites W1970583256 @default.
• W2018368761 cites W1972148963 @default.
• W2018368761 cites W1975787075 @default.
• W2018368761 cites W1986903527 @default.
• W2018368761 cites W2002995168 @default.
• W2018368761 cites W2015927571 @default.
• W2018368761 cites W2017712517 @default.
• W2018368761 cites W2024129268 @default.
• W2018368761 cites W2042907812 @default.
• W2018368761 cites W2045131720 @default.
• W2018368761 cites W2052931181 @default.
• W2018368761 cites W2073013784 @default.
• W2018368761 cites W2073501577 @default.
• W2018368761 cites W2089858439 @default.
• W2018368761 cites W2098760991 @default.
• W2018368761 cites W2115094273 @default.
• W2018368761 cites W2135743020 @default.
• W2018368761 cites W2165090547 @default.
• W2018368761 doi "https://doi.org/10.1016/j.bbrc.2011.12.011" @default.
• W2018368761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22178073" @default.
• W2018368761 hasPublicationYear "2012" @default.
• W2018368761 type Work @default.
• W2018368761 sameAs 2018368761 @default.
• W2018368761 citedByCount "73" @default.
• W2018368761 countsByYear W20183687612012 @default.
• W2018368761 countsByYear W20183687612013 @default.
• W2018368761 countsByYear W20183687612014 @default.
• W2018368761 countsByYear W20183687612015 @default.
• W2018368761 countsByYear W20183687612016 @default.
• W2018368761 countsByYear W20183687612017 @default.
• W2018368761 countsByYear W20183687612018 @default.
• W2018368761 countsByYear W20183687612019 @default.
• W2018368761 countsByYear W20183687612020 @default.
• W2018368761 countsByYear W20183687612021 @default.
• W2018368761 countsByYear W20183687612022 @default.
• W2018368761 countsByYear W20183687612023 @default.
• W2018368761 crossrefType "journal-article" @default.
• W2018368761 hasAuthorship W2018368761A5007919399 @default.
• W2018368761 hasAuthorship W2018368761A5019395170 @default.
• W2018368761 hasAuthorship W2018368761A5025601550 @default.
• W2018368761 hasAuthorship W2018368761A5030624081 @default.
• W2018368761 hasAuthorship W2018368761A5038105097 @default.
• W2018368761 hasAuthorship W2018368761A5039590534 @default.
• W2018368761 hasAuthorship W2018368761A5043599617 @default.
• W2018368761 hasAuthorship W2018368761A5044574879 @default.
• W2018368761 hasAuthorship W2018368761A5057512397 @default.
• W2018368761 hasAuthorship W2018368761A5063448763 @default.
• W2018368761 hasAuthorship W2018368761A5081925386 @default.
• W2018368761 hasAuthorship W2018368761A5090365310 @default.
• W2018368761 hasConcept C104317684 @default.
• W2018368761 hasConcept C10447831 @default.
• W2018368761 hasConcept C105580179 @default.
• W2018368761 hasConcept C145059251 @default.
• W2018368761 hasConcept C153911025 @default.
• W2018368761 hasConcept C190283241 @default.
• W2018368761 hasConcept C194583182 @default.
• W2018368761 hasConcept C22667442 @default.
• W2018368761 hasConcept C502942594 @default.
• W2018368761 hasConcept C54009773 @default.
• W2018368761 hasConcept C54355233 @default.
• W2018368761 hasConcept C54458228 @default.
• W2018368761 hasConcept C67705224 @default.
• W2018368761 hasConcept C86803240 @default.
• W2018368761 hasConcept C89604277 @default.
• W2018368761 hasConcept C95444343 @default.
• W2018368761 hasConceptScore W2018368761C104317684 @default.
• W2018368761 hasConceptScore W2018368761C10447831 @default.
• W2018368761 hasConceptScore W2018368761C105580179 @default.
• W2018368761 hasConceptScore W2018368761C145059251 @default.
• W2018368761 hasConceptScore W2018368761C153911025 @default.
• W2018368761 hasConceptScore W2018368761C190283241 @default.
• W2018368761 hasConceptScore W2018368761C194583182 @default.
• W2018368761 hasConceptScore W2018368761C22667442 @default.
• W2018368761 hasConceptScore W2018368761C502942594 @default.
• W2018368761 hasConceptScore W2018368761C54009773 @default.
• W2018368761 hasConceptScore W2018368761C54355233 @default.
• W2018368761 hasConceptScore W2018368761C54458228 @default.
• W2018368761 hasConceptScore W2018368761C67705224 @default.
• W2018368761 hasConceptScore W2018368761C86803240 @default.

• next